Clinigen Group has appointed Nick Keher as Group chief financial officer effective March 19, 2019. He will replace Martin Abell, who has resigned effective March 31, 2019. Nick joins from Royal Bank of Canada (RBC) where he was a managing director and head of RBC’s European Healthcare equity research team. He has covered the European healthcare space for over eight years at both RBC and Investec. Nick started his career at Lloyd’s Pharmacy, registering as a pharmacist before joining GlaxoS...